Compression therapy for venous leg ulcers: risk factors for adverse events and complications, contraindications - a review of present guidelines

被引:81
作者
Andriessen, A. [1 ,2 ]
Apelqvist, J. [3 ]
Mosti, G. [2 ,4 ]
Partsch, H. [2 ,5 ]
Gonska, C. [6 ]
Abel, M. [2 ,6 ,7 ]
机构
[1] Radboud UMC, Nijmegen & Andriessen Consultants, Malden, Netherlands
[2] ICC, Berndorf, Austria
[3] Univ Hosp Malmo, Dept Endocrinol, Malmo, Sweden
[4] Clin MD Barbantini, Dept Angiol, Lucca, Italy
[5] Med Univ Vienna, Vienna, Austria
[6] Lohmann & Rauscher GmbH & Co KG, Med & Regulatory Affairs, Rengsdorf, Germany
[7] EWMA, POG, Frederiksberg, Denmark
关键词
CLINICAL-PRACTICE-GUIDELINES; INTERMITTENT PNEUMATIC COMPRESSION; RANDOMIZED CONTROLLED-TRIAL; MANAGEMENT; SOCIETY; STOCKINGS; STIFFNESS; BANDAGES; DISEASE; GERMANY;
D O I
10.1111/jdv.14390
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction The adequate use of compression in venous leg ulcer treatment is equally important to patients as well as clinicians. Currently, there is a lack of clarity on contraindications, risk factors, adverse events and complications, when applying compression therapy for venous leg ulcer patients. Methods The project aimed to optimize prevention, treatment and maintenance approaches by recognizing contraindications, risk factors, adverse events and complications, when applying compression therapy for venous leg ulcer patients. A literature review was conducted of current guidelines on venous leg ulcer prevention, management and maintenance. Results Searches took place from 29th February 2016 to 30th April 2016 and were prospectively limited to publications in the English and German languages and publication dates were between January 2009 and April 2016. Twenty Guidelines, clinical pathways and consensus papers on compression therapy for venous leg ulcer treatment and for venous disease, were included. Guidelines agreed on the following absolute contraindications: Arterial occlusive disease, heart failure and ankle brachial pressure index (ABPI) < 0.5, but gave conflicting recommendations on relative contraindications, risks and adverse events. Moreover definitions were unclear and not consistent. Conclusions Evidence-based guidance is needed to inform clinicians on risk factor, adverse effects, complications and contraindications. ABPI values need to be specified and details should be given on the type of compression that is safe to use. Ongoing research challenges the present recommendations, shifting some contraindications into a list of potential indications. Complications of compression can be prevented when adequate assessment is performed and clinicians are skilled in applying compression.
引用
收藏
页码:1562 / 1568
页数:7
相关论文
共 56 条
[1]  
Andriessen AE, 2009, WOUNDS, V21, P127
[2]  
[Anonymous], 2010, MAN CHRON VEN LEG UL
[3]  
[Anonymous], 2011, GUID MAN WOUNDS PAT
[4]  
[Anonymous], 1888INFOFDA
[5]  
[Anonymous], 2011, Australian and New Zealand Clinical Practice Guideline for Prevention and Management of venous Leg Ulcers
[6]  
[Anonymous], 2011, TVS CLIN PRACTICE GU, V2, P18
[7]  
[Anonymous], 2009, UND COMPR THER EWMA
[8]  
[Anonymous], 2009, The ADAPTE process: resource toolkit for guideline adaptation-version 2.0
[9]  
[Anonymous], 2010, ASS ADV WOUND CAR AA
[10]  
[Anonymous], 2009, LEITLINIEN DTSCH GES, V38, P168